Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Konference: 2011 53rd ASH Annual Meeting – účast ČR

Kategorie: Mnohočetný myelom

Téma: 653. Myeloma - Therapy, excluding Transplantation: Novel drugs in relapsed/refractory myeloma patients

Číslo abstraktu: 811

Autoři: Meletios Athanasios Dimopoulos, MD; Sundar Jagannath; MD Sung-Soo Yoon, PhD; MD David Samuel diCapua Siegel, PhD; Prof. MD Sagar Lonial; prof. MUDr. Roman Hájek, CSc.; MD Thierry Facon; MD Laura Rosiñol, PhD; MD Hilary Anne Blacklock; Prof. Dr. med. Hartmut Goldschmidt; Vânia Tietsche de Moraes Hungria; MD Andrew Spencer; MD Antonio P. Palumbo; MD Donna E. Reece, FRCPC; MD Thorsten Graef, PhD; Jeniffer Houp; Linda Sun, PhD; MD Joseph E. Eid; MD Kenneth C. Anderson

Datum přednesení příspěvku: 12. 12. 2011